Page 2 - Syros Pharmaceuticals Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Syros Pharmaceuticals (NASDAQ:SYRS) Issues Earnings Results, Beats Estimates By $0 10 EPS

Syros Pharmaceuticals (NASDAQ:SYRS) Issues Earnings Results, Beats Estimates By $0 10 EPS
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerSyros pharmaceuticalsNews ratings for syros pharmaceuticals dailyEarnings history for syros pharmaceuticalsSyros pharmaceuticals incSyros pharmaceuticals stockGet free reportSyros pharmaceuticals daily

Syros Pharmaceuticals (NASDAQ:SYRS) Releases Earnings Results, Beats Estimates By $0 10 EPS

Syros Pharmaceuticals (NASDAQ:SYRS) Releases Earnings Results, Beats Estimates By $0 10 EPS
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerSyros pharmaceuticalsNews ratings for syros pharmaceuticals dailyEarnings history for syros pharmaceuticalsSyros pharmaceuticals company profileSyros pharmaceuticals incSyros pharmaceuticals stockGet free reportSyros pharmaceuticals daily

Syros Pharmaceuticals (NASDAQ:SYRS) Posts Earnings Results, Beats Expectations By $0 10 EPS

Syros Pharmaceuticals (NASDAQ:SYRS) Posts Earnings Results, Beats Expectations By $0 10 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerSyros pharmaceuticalsEarnings history for syros pharmaceuticalsSyros pharmaceuticals incSyros pharmaceuticals price performanceSyros pharmaceuticals company profileNews ratings for syros pharmaceuticals dailyGet free reportSyros pharmaceuticals daily

Syros Pharmaceuticals (NASDAQ:SYRS) Stock Price Passes Below 50 Day Moving Average of $5 94

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.94 and traded as low as $5.28. Syros Pharmaceuticals shares last traded at $5.44, with a volume of 199,560 shares traded. Wall Street Analysts […]

Piper sandlerSyros pharmaceuticals incSyros pharmaceuticals tradingOpaleye management incNews ratings for syros pharmaceuticals dailySyros pharmaceuticalsFlagship pioneering incInstitutional trading of syros pharmaceuticalsSyros pharmaceuticals company profileGet free reportPartners managementFlagship pioneeringSyros pharmaceuticals dailyNasdaq syrs

Crude Oil Down Over 1%; Cognyte Software Shares Plummet - Cognyte Software (NASDAQ:CGNT), Acrivon Therapeutics (NASDAQ:ACRV)

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0.46% to 38,713.72 while the NASDAQ fell 0.24% to 16,215.32. The S&P 500 also fell, dropping, 0.39% to 5,182.36.

United kingdomCity ofHong kongPhotonics corporationSyros pharmaceuticals incCognyte software ltdVincerx pharma incAcrivon therapeutics incTilray brands incRobinhood to rally aroundAnalyst forecasts for tuesdayBusiness optimism indexAcrivon therapeuticsFast track designationCheck this outBitcoin falls below